{"id":"W2997593504","doi":"10.1002/ajh.25711","title":"Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study","year":2019,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"Bayer","keywords":"Medicine; Internal medicine; Adverse effect; Clinical endpoint; Neutropenia; Pneumonitis; Common Terminology Criteria for Adverse Events; Gastroenterology; Surgery; Diarrhea; Clinical trial; Chemotherapy; Lung","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005165525,0.0004252811,0.001521399,0.0005952788,0.0006262667,0.001243741,0.0004052426,0.0007584268,0.001075944],"category_scores_gemma":[0.003054003,0.0002395244,0.001434844,0.0007606235,0.0002949698,0.001016606,0.0004150269,0.001857539,0.0004027433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00103124,"about_ca_system_score_gemma":0.0007766588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000739506,"about_ca_topic_score_gemma":0.001469668,"domain_scores_codex":[0.9988118,0.000322683,0.0001375588,0.0001556226,0.0003661097,0.0002062595],"domain_scores_gemma":[0.9963124,0.000719678,0.001479181,0.0003542039,0.00059045,0.000544097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09691467,0.004954872,0.5607195,0.001262852,0.005466659,0.001483512,0.0006132298,0.003949163,0.01922217,0.0004078265,0.01169802,0.2933075],"study_design_scores_gemma":[0.01297709,0.06272864,0.8949215,0.0002697284,0.003950451,0.002013427,0.0001522828,0.002875108,0.004658465,0.0005563226,0.01478799,0.0001090632],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728731,0.01614943,0.001125841,0.0004543861,0.00007590208,0.0005104388,0.003402855,0.000105515,0.005302523],"genre_scores_gemma":[0.9876502,0.002079515,0.0005136941,0.001000434,0.0001442052,0.0003400402,0.007114801,0.00002572135,0.001131311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005165525,"threshold_uncertainty_score":0.0273183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00603779465155581,"score_gpt":0.2411114362822258,"score_spread":0.23507364163067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}